Icon PLC (ICLR) (Q3 2026) Earnings Call Highlights: Record
Icon PLC (ICLR) reported Q3 2026 revenue of $2B, down 2.9% YoY. Direct fee revenue growth remains modest, and cancellations are slightly above average. Gross margin improved 90 bps sequentially, and adjusted EBITDA margin rose to 16.6%. The company expects Q4 SG&A expenses to increase and faces ongoing pricing pressure. Management anticipates mid-single-digit revenue growth and higher single-digit earnings growth in 2027, with formal guidance to be provided in Q4.
How this was made

The 30-second read
Why it matters
The earnings miss and lack of forward guidance create downside risk for the stock.
Market read
First‑time disclosure of Q3 results; investors will reassess earnings outlook and valuation.
What to watch
Strong book‑to‑bill of 1.3x suggests pipeline strength despite near‑term revenue dip.
Background
Icon PLC reported Q3 2026 results, highlighting a 2.9% revenue decline, modest fee growth, and margin pressure.
Ticker impact
Q3 earnings show revenue down 2.9% YoY, modest fee growth and margin pressure, with no 2027 guidance yet.
likely downside as investors digest revenue decline and guidance uncertainty
The disclosed numbers are new and materially below expectations, creating immediate pricing pressure.
Market effects
Signals slower growth for the CRO sector and may affect peers with similar fee structures.
UK‑listed CROs could see modest pressure.
Limited to healthcare services investors; no broad market effect.
Counterpoint
If the pass‑through component accelerates, margin recovery could be faster than implied.
Key entities
- CompanyIcon PLC
UK‑based contract research organization.

